Children's National Hospital in Washington, D.C. will halt the prescription and monitoring of gender-affirming medications for transgender youth by August 30. This decision is based on increasing legal and regulatory risks, as the Trump administration has targeted providers of such care. Families are significantly impacted by this change, as they may lose vital support in a region where gender-affirming care remains legal. While mental health support will continue, the cessation of medical care leaves families without important resources. All major U.S. medical associations endorse gender-affirming care as safe and evidence-based.
Children's National Hospital in Washington, D.C., will stop prescribing and monitoring gender-affirming medications for transgender youth by August 30, citing "escalating legal and regulatory risks" as the Trump administration targets providers of such care in its ongoing effort to eliminate transgender people from American society.
The hospital acknowledged the significance of the decision in a statement, recognizing the impact this has had on families and expressing a commitment to providing support.
The change follows the Department of Justice's issuance of over 20 subpoenas to doctors and clinics offering gender-affirming care for minors, asserting accountability for "mutilating children in the service of a warped ideology."
All major U.S. medical associations support gender-affirming care as safe and evidence-based, despite the hospital's decision amidst legal challenges.
Collection
[
|
...
]